Home » Newsletters » BioWorld Science

BioWorld Science

March 25, 2020

View Archived Issues

Brown fat activity without fat browning

FDA lifts hold and clears IND application for IMS-001

Agonists selectively wake up melatonin receptor subtypes

IND application for AG-946 cleared by FDA

Enhancing TREM2's protective function on microglia as a novel approach for Alzheimer's disease

Ciclesonide shows antiviral activity against SARS-CoV-2

First patients enrolled in RECOVERY study evaluating potential COVID-19 treatments

Vaccitech presents initial data from phase IIa ADVANCE study of VTP-800

miR-423-5p and miR-128-3p in serum exosome as biomarkers for testicular injury

Novel lipid biomarkers for ETH-induced hepatic steatosis

Elevated AXIN1 expression as predictor of PTSD development

TNFSF14 is a therapeutic target in eosinophilic esophagitis

Biomarkers predict renal recovery from acute kidney injury requiring dialysis

Nanocells deliver cytotoxin, activate immune system

Roche and Genentech patent TEAD inhibitors

Novartis divulges new compounds for herpesvirus infection

H. Lee Moffitt Cancer Center and Research Institute presents BRD4-JAK2 inhibitors

Otsuka Pharmaceutical identifies AhR antagonists

New AMPK activators presented by Skylark Bioscience

Ascletis publishes data from clinical study of danoprevir for COVID-19

Novartis' Beovu approved in Japan for neovascular age-related macular degeneration

Japanese approval of Tepmetko for advanced NSCLC with METex14 skipping alterations

Phase I results with losmapimod for FSHD show target engagement in muscle

Antolimab begins new trials, shows promise for mast cell gastrointestinal disease

BeiGene studies BGB-11417 in phase I for mature B-cell malignancies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...